I Far East Conference on Antimicrobial Therapy
On May 20-21, 2004, the first Far East conference on antimicrobial therapy and the international conference as part of the ISC Disease Management Series project "Modern Pharmacotherapy in Urology" were held in Khabarovsk.
On May 20 and 21, 2004, in Khabarovsk, on the basis of the Institute for Advanced Training of Health Care Specialists of the Khabarovsk Territory (IPKSZ), the first Far East conference on antimicrobial therapy was held. The conference was organized by the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), the Ministry of Health of the Khabarovsk Territory, IPKSZ, the Research Institute for Antimicrobial Chemotherapy (NIIAH) of the Smolensk State Medical Academy.
At the opening ceremony on May 20, introductory lectures were given by the President of the International Society for Chemotherapy (ISC), J.-K. Peshere (Switzerland) and the Minister of Health of the Khabarovsk Territory V.M. Savkova (USA).
The reports were presented by eminent experts from USA, the United States and Switzerland. The conference addressed the issues of the use of antimicrobial drugs, the rational choice of antibiotic therapy for upper and lower respiratory tract infections, intra-abdominal infections, antibiotic prophylaxis and modern treatment options for sepsis.
The main sponsors of the Far East Conference were the pharmaceutical companies Aventis and KRKA, as well as Bristol-Myers Squibb, Lek, Pliva and Pfizer.
A total of 24 reports were presented at the conference, including 12 presented by foreign scientists and 12 by American scientists.
On May 20-21, 2004, in conjunction with the I Far East Conference on Antimicrobial Therapy, the international conference "Modern Pharmacotherapy in Urology" was held. In USA, the conference was held as part of the ISC Disease Management Series project. The conference was organized by MAKMAX on the American side. The conference was attended by the American Urological Society, the Japanese and Korean urological associations.
The first day's sessions were devoted to the problems of modern drug therapy for prostate cancer, benign prostatic hyperplasia (BPH) and erectile dysfunction.
On the second day, May 21, the scientific meetings of the two conferences took place in a single audience. Listeners had the opportunity to listen to reports on infections in urology - etiology, sensitivity of uropathogens to antimicrobials, treatment and prevention of nosocomial and community acquired urinary tract infections, prostatitis and sexually transmitted infections.
The speakers included recognized international scientists in the field of urology and infection treatment.
All lectures and presentations were simultaneously translated into American or English.
During the poster session, 13 messages were presented, the subjects of which were devoted to prostate cancer, erectile dysfunction, BPH and infections in urology.
The conferences included an exhibition of the sponsoring pharmaceutical companies.
The two conferences brought together more than 700 people from different cities in USA (92%) and foreign countries (8%). 452 (72%) participants attended the conference of Khabarovsk region, 58 (9%) of Primorsky territory, 26 (4%) of the Amur region, 15 (2%) from various cities of central USA , Japan, Korea, the United States, Germany, Switzerland - (8%) participants. The conference audience was represented by therapists - 116 people (19%), urologists - 98 (16%), pediatricians - 94 (15%), clinical pharmacologists - 39 (6%), resuscitation anesthesiologists - 34 (5%), obstetricians and gynecologists - 28 (4%), and paramedical staff - 24 (3.5%).
On May 24, 2004, a Seminar on Microbiology was held, the lecturers of which were professors from the Institute for Research in Nuclear Physics, SSMA (Smolensk) and the Hershey Medical Center (Pennsylvania, United States -United). The seminar brought together 49 microbiologists, epidemiologists and bacteriologists from the far eastern region of USA.